Although there has been steady uptake of targeted therapies across LOTs, unmet need persists for patients with CLL/SLL who receive later LOTs. The time to the next treatment decreased with each LOT, ...

Study authors examined the diagnostic utility of radiologic imaging for patients with high-risk cutaneous squamous cell carcinoma.

Researchers sought to determine whether lisocabtagene maraleucel would have efficacy for patients with LBCL in a real-world setting.

HealthDay News — Annual multicancer early detection (MCED) screening with a single blood test provides more overall benefit than biennial MCED screening, according to a study published online May 8 in ...

In a population-based case-control study, researchers assessed the risk for brain tumors following radiation from CT scans among pediatric patients.

Parents of children with ALL experience a high financial burden during the early phase of their child’s treatment trajectory.

Tumor-infiltrating clonal hematopoiesis was associated with a greater risk of recurrence or death in patients with non-small-cell lung cancer.

UHF noninferior to conventionally fractionated radiotherapy for men with intermediate- to high-risk localized disease.

Pembrolizumab plus CRT produced “robust and durable anti-tumor activity” in the KEYNOTE-799 trial, said Martin Reck, MD, PhD.

Researchers examined the addition of 3D total-body photography and sequential digital dermoscopy imaging to usual care on outcomes in patients at high risk for melanoma.

A retrospective analysis revealed that palliative care continues to be underutilized in patients with cervical cancer.

The Food and Drug Administration (FDA) has approved the combination of nivolumab (Opdivo ®) plus ipilimumab (Yervoy ® ), both from Bristol Myers Squibb Company, as an option for first-line therapy for ...